search
Back to results

Effectiveness of Probiotic Supplementation on Crying Time in Infantile Colic

Primary Purpose

Colic, Infantile

Status
Withdrawn
Phase
Not Applicable
Locations
Indonesia
Study Type
Interventional
Intervention
Lactobacillus reuteri DSM17938
Placebo
Sponsored by
BioGaia AB
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Colic, Infantile

Eligibility Criteria

undefined - 3 Months (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • otherwise healthy infants
  • Infantile colic according to Roe IV criteria
  • Full term infants
  • Birth weight 2500 - 4000g
  • Exclusively breast milk or partially breastfed
  • Mothers last education degree is Senior high school

Exclusion Criteria

  • Clinically suspected allergy
  • Consumption of probiotics, antibiotics, PPI
  • Failure to thrive

Sites / Locations

  • Badriul Hegar

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Lactobacillus reuteri DSM17938

Placebo

Arm Description

Oil drops

Oils drops

Outcomes

Primary Outcome Measures

Daily average of crying time with L reuteri vs placebo
Daily crying diary
Daily average of crying time with L reuteri vs placebo
Daily crying diary
Daily average of crying time with L reuteri vs placebo
Daily crying diary
Daily average of crying time with L reuteri vs placebo
Daily crying diary

Secondary Outcome Measures

Number of responder vs non-responders
Daily crying
Reduction of daily average crying time
Daily crying
Parents perception of colic severity (Diary)
Diary
Parents/Family quality of life (Diary)
Diary
Parental satisfactory (Diary)
Diary

Full Information

First Posted
March 24, 2017
Last Updated
May 2, 2022
Sponsor
BioGaia AB
search

1. Study Identification

Unique Protocol Identification Number
NCT03106285
Brief Title
Effectiveness of Probiotic Supplementation on Crying Time in Infantile Colic
Official Title
Effectiveness of Lactobacillus Reuteri DSM17938 Supplementation on Crying Time in Infantile Colic
Study Type
Interventional

2. Study Status

Record Verification Date
May 2022
Overall Recruitment Status
Withdrawn
Why Stopped
Cannot perform the study due to practical issues
Study Start Date
April 14, 2017 (Actual)
Primary Completion Date
May 1, 2019 (Actual)
Study Completion Date
July 1, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
BioGaia AB

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study aims to investigate the effectiveness of Lactobacillus reuteri DSM17938 supplementation on infantile colic in Indonesian infants.
Detailed Description
Infantile colic is a problem faced by many parents and caregivers. There is no evidence that medications does help in this situation. The etiology of infantile colic is still unknown. Lactobacillus reuteri has been shown in five studies to reduce crying time in infants diagnosed with infantile colic.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Colic, Infantile

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
0 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Lactobacillus reuteri DSM17938
Arm Type
Experimental
Arm Description
Oil drops
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Oils drops
Intervention Type
Dietary Supplement
Intervention Name(s)
Lactobacillus reuteri DSM17938
Intervention Description
5 drops of active oil drops. The active dose consists of 10^8 CFU L retueri DSM17938
Intervention Type
Dietary Supplement
Intervention Name(s)
Placebo
Intervention Description
5 drops of placebo drops
Primary Outcome Measure Information:
Title
Daily average of crying time with L reuteri vs placebo
Description
Daily crying diary
Time Frame
day 7
Title
Daily average of crying time with L reuteri vs placebo
Description
Daily crying diary
Time Frame
Day 14
Title
Daily average of crying time with L reuteri vs placebo
Description
Daily crying diary
Time Frame
Day 21
Title
Daily average of crying time with L reuteri vs placebo
Description
Daily crying diary
Time Frame
Day 28
Secondary Outcome Measure Information:
Title
Number of responder vs non-responders
Description
Daily crying
Time Frame
baseline, day 7, 14, 21, 28
Title
Reduction of daily average crying time
Description
Daily crying
Time Frame
baseline, day 7, 14, 21, 28
Title
Parents perception of colic severity (Diary)
Description
Diary
Time Frame
baseline, day 7, 14, 21, 28
Title
Parents/Family quality of life (Diary)
Description
Diary
Time Frame
baseline, day 7, 14, 21, 28
Title
Parental satisfactory (Diary)
Description
Diary
Time Frame
baseline, day 7, 14, 21, 28

10. Eligibility

Sex
All
Maximum Age & Unit of Time
3 Months
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: otherwise healthy infants Infantile colic according to Roe IV criteria Full term infants Birth weight 2500 - 4000g Exclusively breast milk or partially breastfed Mothers last education degree is Senior high school Exclusion Criteria Clinically suspected allergy Consumption of probiotics, antibiotics, PPI Failure to thrive
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Badriul Hegar, MD, PhD
Organizational Affiliation
RSCM, Rumah Sakit Cipto Mangunkusumo. University of Indonesia
Official's Role
Principal Investigator
Facility Information:
Facility Name
Badriul Hegar
City
Jakarta
Country
Indonesia

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Effectiveness of Probiotic Supplementation on Crying Time in Infantile Colic

We'll reach out to this number within 24 hrs